(Q37989159)

26 August 2017

title

Nonalcoholic fatty liver disease and bariatric surgery (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

26 August 2017

0 references

0 references

1 reference

1 reference

Sindu Stephen

1

1 reference

26 August 2017

Ancha Baranova

series ordinal

2

1 reference

26 August 2017

Zobair M Younossi

series ordinal

3

1 reference

26 August 2017

language of work or name

1 reference

1 April 2012

1 reference

Expert Review of Gastroenterology & Hepatology

26 August 2017

published in

1 reference

26 August 2017

volume

6

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

163-171

1 reference

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

26 August 2017

cites work

1 reference

Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.

21 January 2018

1 reference

NASH: A global health problem

21 January 2018

1 reference

Expert panel on weight loss surgery: executive report update

21 January 2018

1 reference

Pathology of nonalcoholic steatohepatitis

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

21 January 2018

1 reference

Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

21 January 2018

1 reference

The role of the lipogenic pathway in the development of hepatic steatosis.

21 January 2018

1 reference

Inflammation in nonalcoholic steatohepatitis

21 January 2018

1 reference

Mitochondrial dysfunction in nonalcoholic steatohepatitis

21 January 2018

1 reference

Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

21 January 2018

1 reference

Obesity affects the liver - the link between adipocytes and hepatocytes.

21 January 2018

1 reference

Adipokines and melanocortins in the hepatic manifestation of metabolic syndrome: nonalcoholic fatty liver disease.

21 January 2018

1 reference

A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes?

21 January 2018

1 reference

Obesity, Inflammation, and Insulin Resistance

21 January 2018

1 reference

Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients

21 January 2018

1 reference

Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

Identification and characterization of metabolically benign obesity in humans

21 January 2018

1 reference

Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively?

21 January 2018

1 reference

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

21 January 2018

1 reference

Dietary composition and nonalcoholic fatty liver disease

21 January 2018

1 reference

Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

21 January 2018

1 reference

Endocannabinoids and their role in fatty liver disease.

21 January 2018

1 reference

The sibutramine metabolite M2 improves muscle glucose uptake and reduces hepatic glucose output: preliminary data

21 January 2018

1 reference

Treatment with sibutramine prior to Roux-en-Y gastric bypass leads to an improvement of metabolic parameters and to a reduction of liver size and operative time

21 January 2018

1 reference

Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study

21 January 2018

1 reference

Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

21 January 2018

1 reference

American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support of the bari

21 January 2018

1 reference

NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery--a prospective analysis.

21 January 2018

1 reference

Bariatric surgery: a systematic review of the clinical and economic evidence

21 January 2018

1 reference

Laparoscopic Placement of Adjustable Silicone Gastric Band in the Treatment of Morbid Obesity: How to Do It.

21 January 2018

1 reference

A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years.

21 January 2018

1 reference

Jejunoileal bypass for morbid obesity. A critical appraisal

21 January 2018

1 reference

Bariatric surgery: a review of procedures and outcomes

21 January 2018

1 reference

Current status of medical and surgical therapy for obesity

21 January 2018

1 reference

Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or = 50 kg/m2) compared with gastric bypass.

21 January 2018

1 reference

Hepatic effects of dietary weight loss in morbidly obese subjects

21 January 2018

1 reference

Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement

21 January 2018

1 reference

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

21 January 2018

1 reference

Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content.

21 January 2018

1 reference

Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression.

21 January 2018

1 reference

Cirrhosis is not a contraindication to laparoscopic surgery

21 January 2018

1 reference

Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation

21 January 2018

1 reference

Results of laparoscopic gastric bypass in patients with cirrhosis

21 January 2018

1 reference

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

21 January 2018

1 reference

Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis

21 January 2018

1 reference

Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity.

21 January 2018

1 reference

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.11.97

1 reference

26 August 2017

1 reference